Acrux Ltd (ACR)

Currency in AUD
0.017
+0.001(+6.25%)
Closed·
ACR Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ACR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0170.017
52 wk Range
0.0150.079
Key Statistics
Bid/Ask
0.016 / 0.017
Prev. Close
0.016
Open
0.017
Day's Range
0.017-0.017
52 wk Range
0.015-0.079
Volume
183.99K
Average Volume (3m)
380.96K
1-Year Change
-74.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Acrux Ltd Company Profile

Acrux Limited, together with its subsidiaries, engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; Dapsone 5% and Dapsone 7.5% which are gels for the treatment of acne vulgaris; and Prilocaine 2.5% and Lidocaine 2.5%, a topical anaesthetic cream. It is also involved in the development of Efinaconazole, a topical solution used to treat fungal infections of toenails; Nitroglycerin 0.4%, an ointment for the treatment of pain caused by chronic anal fissure; and Acyclovir 5%, a cream for the treatment of cold sores. The company was incorporated in 1998 and is based in West Melbourne, Australia.

Employees
43
Market
Australia

Compare ACR to Peers and Sector

Metrics to compare
ACR
Peers
Sector
Relationship
P/E Ratio
−1.2x−6.0x−0.5x
PEG Ratio
0.00−0.030.00
Price/Book
2.0x1.5x2.6x
Price / LTM Sales
8.6x9.7x3.2x
Upside (Analyst Target)
-159.1%45.7%
Fair Value Upside
Unlock15.5%8.6%Unlock

Earnings

Latest Release
Feb 25, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
120.00K / --
EPS Revisions
Last 90 days

ACR Income Statement

FAQ

What Stock Exchange Does Acrux Trade On?

Acrux is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Acrux?

The stock symbol for Acrux is "ACR."

What Is the Acrux Market Cap?

As of today, Acrux market cap is 6.93M.

What Is Acrux's Earnings Per Share (TTM)?

The Acrux EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is ACR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Acrux Stock Split?

Acrux has split 0 times.

How Many Employees Does Acrux Have?

Acrux has 43 employees.

What is the current trading status of Acrux (ACR)?

As of 02 Aug 2025, Acrux (ACR) is trading at a price of 0.02, with a previous close of 0.02. The stock has fluctuated within a day range of 0.02 to 0.02, while its 52-week range spans from 0.02 to 0.08.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.